BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11948700)

  • 1. Ex vivo expansion of apheresis-derived peripheral blood hematopoietic progenitors.
    Estrov Z; Huh YO; Ginsberg CF; Harris D; Van Q; Mirza NQ; Talpaz M; Korbling M
    J Clin Apher; 2002; 17(1):7-16. PubMed ID: 11948700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
    Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
    J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored.
    Ruggieri L; Heimfeld S; Broxmeyer HE
    Blood Cells; 1994; 20(2-3):436-54. PubMed ID: 7538350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expansion of granulocyte colony-stimulating factor/chemotherapy-mobilized CD34+ hematopoietic progenitors: role of granulocyte-macrophage colony-stimulating factor/erythropoietin hybrid protein (MEN11303) and interleukin-15.
    Pierelli L; Scambia G; Bonanno G; Coscarella A; De Santis R; Mele A; Battaglia A; Fattorossi A; Romeo V; Menichella G; Mancuso S; Leone G
    Exp Hematol; 1999 Mar; 27(3):416-24. PubMed ID: 10089903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal serum-free culture of purified human CD34+ cells: amplification of progenitors from G-CSF and GM-CSF-mobilized peripheral blood.
    Schain LR; Jain S; Wysocki M; Hall M; Dadey B; Pennathur-Das R; Biddle W; Wolf J; Okarma TB; Lebkowski JS
    J Hematother; 1997 Aug; 6(4):335-49. PubMed ID: 9377072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of progenitor enrichment, serum, and cytokines on the ex vivo expansion of mobilized peripheral blood stem cells: a controlled trial.
    Balducci E; Azzarello G; Valenti MT; Capuzzo GM; Pappagallo GL; Pilotti I; Ausoni S; Bari M; Rosetti F; Sartori D; Ciappa A; Porcellini A; Vinante O
    Stem Cells; 2003; 21(1):33-40. PubMed ID: 12529549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The activity in ex vivo expansion of cord blood myeloid progenitor cells before and after cryopreservation.
    Wang SY; Hsu ML; Huang MZ; Hsu HC; Tzeng CH; Hung JH; Ho CK
    Acta Haematol; 2001; 105(1):38-44. PubMed ID: 11340252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical ex vivo expansion of cord blood hematopoietic stem and progenitor cells: duration of culture; the media, serum supplements, and growth factors used; and engraftment in NOD/SCID mice.
    Lam AC; Li K; Zhang XB; Li CK; Fok TF; Chang AM; James AE; Tsang KS; Yuen PM
    Transfusion; 2001 Dec; 41(12):1567-76. PubMed ID: 11778074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.
    Kobari L; Pflumio F; Giarratana M; Li X; Titeux M; Izac B; Leteurtre F; Coulombel L; Douay L
    Exp Hematol; 2000 Dec; 28(12):1470-80. PubMed ID: 11146169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective ex vivo generation of granulopoietic postprogenitor cells from mobilized peripheral blood CD34(+) cells.
    Scheding S; Meister B; Bühring HJ; Baum CM; Mc Kearn JP; Bock T; Kanz L; Brugger W
    Exp Hematol; 2000 Apr; 28(4):460-70. PubMed ID: 10781904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum-free ex vivo expansion of CD34(+) hematopoietic progenitor cells.
    Möbest D; Mertelsmann R; Henschler R
    Biotechnol Bioeng; 1998 Nov; 60(3):341-7. PubMed ID: 10099437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful short-term ex vivo expansion of NOD/SCID repopulating ability and CAFC week 6 from umbilical cord blood.
    Kusadasi N; van Soest PL; Mayen AE; Koevoet JL; Ploemacher RE
    Leukemia; 2000 Nov; 14(11):1944-53. PubMed ID: 11069030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expansion and differentiation of cord blood products using a two-step expansion culture.
    McNiece I; Kubegov D; Kerzic P; Shpall EJ; Gross S
    Exp Hematol; 2000 Oct; 28(10):1181-6. PubMed ID: 11027837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells.
    Kobari L; Giarratana MC; Pflumio F; Izac B; Coulombel L; Douay L
    J Hematother Stem Cell Res; 2001 Apr; 10(2):273-81. PubMed ID: 11359674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo expansion of CD34 + CD38- cord blood cells.
    De Bruyn C; Delforge A; Bron D; Bernier M; Massy M; De Hemptinne D; Stryckmans P
    J Hematother; 1997 Apr; 6(2):93-102. PubMed ID: 9131438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replating potential of colony-forming units of granulocytes/macrophages (CFU-GM) expanded ex vivo by stem cell factor, interleukin (IL)-3, IL-6, granulocyte colony-stimulating factor, erythropoietin with or without thrombopoietin.
    Katayama Y; Takenaka K; Mahmut N; Teshima T; Shinagawa K; Omoto E; Harada M
    Int J Hematol; 1998 Aug; 68(2):157-68. PubMed ID: 9803674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential modulation of adhesion markers with ex vivo expansion of human umbilical CD34+ progenitor cells.
    Reems JA; Mielcarek M; Torok-Storb B
    Biol Blood Marrow Transplant; 1997 Aug; 3(3):133-41. PubMed ID: 9310190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.